Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda
Gabriel Chamie, MD
HIV/AIDS , Tuberculosis , Epidemiology and Surveillance
Uganda
6/1/11
5/31/16
Family-Based HIV Voluntary Testing and Counseling in Patients at Risk for Tuberculosis
Edwin Charlebois, PhD
HIV/AIDS , Tuberculosis , Implementation and Behavioral Science
Uganda
5/10/06
12/31/12
Women, Children, and HIV Website
Susan Coffey, MD
HIV/AIDS , Women's Health , Patient and Peer Education
United States
7/1/09
6/30/10
HIV-HEP C Website Maintenance Services
Susan Coffey, MD
Infectious Disease , HIV/AIDS , Patient and Peer Education
United States
4/1/09
12/31/10
AETC National Resource Center / AIDS Education and Training Website
Susan Coffey, MD
HIV/AIDS , Training and Capacity Building
United States
9/1/11
6/30/13
Adolescent Modules - AETC Web Site
Susan Coffey, MD
HIV/AIDS , Systematic Reviews and Guideline Development , Training and Capacity Building
United States
3/17/05
9/17/05
Adolescent Modules - AETC Web Site (Cont.)
Susan Coffey, MD
HIV/AIDS , Systematic Reviews and Guideline Development , Training and Capacity Building
United States
9/18/05
9/26/07
Women, Children, and HIV Website (DBS)
Susan Coffey, MD
HIV/AIDS , Women's Health , Pediatrics , Newborn and Infant Health
United States
4/1/07
3/31/08
VA HIV Website
Susan Coffey, MD
HIV/AIDS
United States
12/1/04
9/30/05
UMDNJ / WHO Dept. of HIV/AIDS "Development of an Annotated Inventory of PMTCT Tools and Guidelines"
Susan Coffey, MD
HIV/AIDS , Women's Health , Pediatrics , Newborn and Infant Health
Kenya
3/1/07
6/30/07
UMDNJ / "Tanzania PMTCT Training Package"
Susan Coffey, MD
HIV/AIDS , Women's Health , Pediatrics , Training and Capacity Building
Tanzania
2/1/07
4/30/08
VA HIV-HEP C Website Maintenance Services
Susan Coffey, MD
HIV/AIDS , Health Systems Strengthening , Training and Capacity Building , Patient and Peer Education
United States
10/1/12
3/31/15
Women, Children, and HIV Website
Susan Coffey, MD
HIV/AIDS , Women's Health , Labor and Delivery , Family Planning , Pediatrics , Newborn and Infant Health , Training and Capacity Building
Kenya ; Malawi ; Mauritius ; Mozambique ; Rwanda ; Seychelles ; Somalia ; Uganda ; Tanzania ; Zambia ; Zimbabwe ; Angola ; Cameroon ; Central African Republic ; Chad ; Botswana ; Lesotho ; Namibia ; South Africa ; Swaziland ; Gambia ; Ghana ; Liberia ; Nigeria ; India ; Pakistan ; Sri Lanka ; Singapore ; Philippines ; United Kingdom ; Anguilla ; Antigua and Barbuda ; Bahamas ; Barbados ; Cayman Islands ; Dominica ; Grenada ; Jamaica ; Saint Kitts and Nevis ; Saint Lucia ; Trinidad and Tobago ; U.S. Virgin Islands ; Northern Mariana Islands ; Australia ; Marshall Islands ; Palau ; Papua New Guinea ; Samoa ; Solomon Islands ; Tokelau ; Tonga ; Tuvalu ; Vanuatu
9/1/11
8/31/14
Master Agreement: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS
Steven Deeks, MD
HIV/AIDS
United States
8/20/12
8/19/17
HIV Entry Inhibitors: A New Therapeutic Option
Steven Deeks, MD
HIV/AIDS , Immunology
United States
7/1/06
6/30/11
Core B: Specimen Repository Core
Steven Deeks, MD
United States
8/1/08
7/31/14
Impact of HIV-Associated Inflammation on Disease
Steven Deeks, MD
HIV/AIDS
United States
6/21/12
5/31/17
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
9/26/09
8/31/12
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT
Steven Deeks, MD
HIV/AIDS
Uganda ; South Africa ; Mali ; Nigeria ; China ; Malaysia ; Thailand ; Mexico ; Argentina ; Brazil ; Chile ; Peru ; Uruguay
12/1/06
5/31/11
Short-Term Disulfiram Administration to Reverse Latent HIV Infection
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
9/1/12
8/31/13
EraMune Project
Steven Deeks, MD
United States
5/5/10
12/17/13
DARE: Delaney AIDS Research Enterprise to Find a Cure
Steven Deeks, MD
HIV/AIDS
Sweden ; Australia
7/8/11
6/30/17
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
Steven Deeks, MD
HIV/AIDS
Tanzania ; Zambia ; Morocco ; South Africa ; Mali ; Thailand ; Greece ; Argentina ; Brazil ; Chile ; Peru
6/29/06
5/31/16
Task Order: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS
Steven Deeks, MD
United States
9/1/12
8/31/13
Atripla Adherence and Resistance Relationships [I]
Steven Deeks, MD
HIV/AIDS , Treatment Adherence
United States
10/1/07
8/31/10
Enfuvirtide Intensification for Multi-Drug Resistant HIV
Steven Deeks, MD
Zoonosis, Emerging Disease, and Drug Resistance , HIV/AIDS , Pharmacology and Drug Treatment
United States
11/1/04
10/31/06
Elite Controllers
Steven Deeks, MD
HIV/AIDS , Immunology , Genetics
United States
11/1/07
10/31/08
Atripla Adherence and Resistance Relationships [II]
Steven Deeks, MD
HIV/AIDS , Treatment Adherence
United States
1/24/08
8/31/10
Enhancing Control of HIV by Inhibiting TRAIL
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development , Immunology
United States
7/2/13
6/30/18
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response
Steven Deeks, MD
HIV/AIDS , Immunology
United States
2/1/08
11/1/10
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes
Steven Deeks, MD
HIV/AIDS
United States
8/15/13
7/31/15
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
12/9/03
3/31/05
Treating HIV-infected Elite Controllers as a Model of HIV Remission
Steven Deeks, MD
HIV/AIDS
United States
7/9/10
7/8/13
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
8/23/02
8/23/04
Identifying and Targeting HIV Persistence in T Cell Subsets during ART
Steven Deeks, MD
HIV/AIDS
United States
6/1/13
5/31/14
Innate Effector Function and HIV-1 Control
Steven Deeks, MD
HIV/AIDS , Immunology
United States
5/22/09
4/30/11
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation
Steven Deeks, MD
HIV/AIDS
United States
9/1/10
8/31/12
Long Term Follow-Up of Patients Enrolled in Clinical Trials (#A-9602, A-9604, A-9801) Using Retroviral Gene Based Therapies / AIDS related research
Steven Deeks, MD
HIV/AIDS
United States
12/15/99
12/15/09
Preventing the Establishment of Enfuvirtide-Resistance in the Latent Reservoir
Steven Deeks, MD
HIV/AIDS
United States
5/1/07
4/30/12
HIV Specific T-Cell Responses in Rectal Mucosa
Steven Deeks, MD
HIV/AIDS
United States
2/1/08
1/31/14
Disulfiram to Accelerate Decay in HIV Reservoirs in ART Treated Patients
Steven Deeks, MD
HIV/AIDS
United States
4/1/11
6/30/12
HIV Persistence after Successful CCR5-Depleted Stem Cell Transplantation
Steven Deeks, MD
HIV/AIDS
United States
10/1/11
9/30/13
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296
Steven Deeks, MD
HIV/AIDS , Noncommunicable and/or Chronic Disease , Pharmacology and Drug Treatment
United States
6/1/12
5/31/13
T Regulatory Cells and T Cell Activation in HIV Disease
Steven Deeks, MD
HIV/AIDS , Immunology
United States
9/1/02
2/28/07
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
4/4/06
12/31/06
Epigenetic Regulation of HIV Latency
Steven Deeks, MD
HIV/AIDS
United States
7/1/10
2/28/15
Treatment Intensification for Drug-Resistant HIV
Steven Deeks, MD
HIV/AIDS
United States
5/1/03
4/30/06
HIV Controllers: A Potential Model for HIV Eradication
Steven Deeks, MD
HIV/AIDS , Immunology
United States
7/1/06
6/30/07
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development
South Africa ; Mali ; Brazil ; Peru
12/1/06
5/31/11
San Francisco National Clinical Trial Center, ESPIRIT
Steven Deeks, MD
HIV/AIDS , Pharmacology and Drug Treatment
Morocco ; Japan ; Singapore ; Thailand ; Israel ; Austria ; Belgium ; Denmark ; France ; Germany ; Ireland ; Italy ; Netherlands ; Norway ; Poland ; Portugal ; Spain ; United Kingdom ; Argentina ; Brazil ; Canada ; Australia
8/1/05
7/31/07
UCSF/Ragon Collaboration on HIV "Elite" Controllers
Steven Deeks, MD
HIV/AIDS , Drug and Diagnostics Development , Immunology , Genetics
United States
9/1/09
8/31/11
Assessing Antiretroviral Exposure in Diverse Populations
Monica Gandhi, MD, MPH
HIV/AIDS , Pharmacology and Drug Treatment
United States
9/15/05
7/31/12
Determination of Reyataz (Atazanavir Sulfate) Levels in Hair: A New Assay and Possible Predictor for Long-Term Virologic Outcome
Monica Gandhi, MD, MPH
Implementation and Behavioral Science , Treatment Adherence
United States
9/1/05
12/31/06
Developing a Mentoring Network of Diverse Mental Health Professionals Utilizing the CNICS Platform
Monica Gandhi, MD, MPH
Residencies, Fellowships, and Postdoctoral Training
United States
7/11/11
6/30/14
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials
Monica Gandhi, MD, MPH
HIV/AIDS
Uganda
12/15/11
11/30/16
Early Mortality in HIV-Infected Patients Starting Antiretroviral Therapy in Africa
HIV/AIDS , Pharmacology and Drug Treatment
Uganda
9/25/09
7/31/14
R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS
HIV/AIDS , Implementation and Behavioral Science , Engagement in Care
United States
9/1/11
8/31/16
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study
HIV/AIDS , Pharmacology and Drug Treatment
United States
6/23/12
12/22/15
Treating HIV-Infected Elite Controllers as a Model of HIV Remission
HIV/AIDS
United States
5/17/10
4/25/14
Virologic and Host Factors Contributing to HIV Control in Elite Controllers
HIV/AIDS
United States
6/15/07
5/31/12
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients
HIV/AIDS , Immunology
United States
6/11/10
6/10/11
Feasibility of a Point-Of-Care CD4+ Test
United States
2/17/12
2/16/15
Treating HIV-Infected Elite Controllers as a Model of HIV Remission
HIV/AIDS , Immunology
United States
4/1/09
3/31/12
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals
HIV/AIDS , Cardiovascular Disease
United States
7/1/12
6/30/15
Administration of an ACE-Inhibitor to Decrease the Latent Reservoir
HIV/AIDS
United States
11/1/11
10/31/12
Therapeutic Strategies for HIV Disease
Diane Havlir, MD
HIV/AIDS
Uganda
4/15/02
3/31/08
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II)
Diane Havlir, MD
HIV/AIDS
Uganda
7/20/09
7/19/14
AIDS Research and Services at SF General Hospital
Diane Havlir, MD
HIV/AIDS , Engagement in Care , Treatment Adherence , Risk Reduction and Prevention
United States
7/1/12
6/30/13
Neurological AIDS Research Consortium
Diane Havlir, MD
HIV/AIDS
United States
12/1/11
9/30/12
AIDS Research and Services at SFGH
Diane Havlir, MD
HIV/AIDS
United States
7/1/02
6/30/12
Task Order Agreement No. CRB-DCR01-S-09-00325
Diane Havlir, MD
Drug and Diagnostics Development
United States
11/1/09
3/31/13
Productive and Latent HIV Infection in Gut Mucosal Reservoirs
Diane Havlir, MD
HIV/AIDS
United States
12/1/11
8/31/13
Task Order Supplement to A5267
Diane Havlir, MD
HIV/AIDS , Tuberculosis , Pharmacology and Drug Treatment
United States
6/1/10
5/31/11
HIV/TB in Uganda: Punctuated Antiretroviral Therapy
Diane Havlir, MD
HIV/AIDS , Tuberculosis
Uganda ; South Africa
9/1/08
2/28/10
UCSF HIV Clinical Trials Unit
Diane Havlir, MD
HIV/AIDS
United States
1/1/07
5/30/14
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)
Diane Havlir, MD
HIV/AIDS
Uganda
7/1/12
6/30/15
International AIDS Research and Prevention
Diane Havlir, MD
HIV/AIDS
Uganda
7/1/04
6/30/05
Sustainable East Africa Research in Community Health
Diane Havlir, MD
HIV/AIDS , Epidemiology and Surveillance , Engagement in Care , Treatment Adherence , Health Systems Strengthening , Risk Reduction and Prevention , Training International Scholars and Clinicians , Residencies, Fellowships, and Postdoctoral Training
Kenya ; Uganda
5/13/13
6/30/20
UCSF HIV/AIDS Management Training Programs
Diane Havlir, MD
HIV/AIDS , Training and Capacity Building
United States
9/1/05
10/31/05
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services
Diane Havlir, MD
HIV/AIDS , Tuberculosis
United States
6/1/12
12/31/13
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III)
Diane Havlir, MD
HIV/AIDS , Malaria
Uganda
10/17/09
10/16/14
AIDS Clinical Trials Group (ACTG) TTSG Services
Diane Havlir, MD
HIV/AIDS
United States
6/1/11
5/31/12
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298
Diane Havlir, MD
HIV/AIDS , Opportunistic Infection , Tuberculosis , Oral Health
Uganda
6/1/12
12/31/13
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257)
Diane Havlir, MD
HIV/AIDS , Pharmacology and Drug Treatment
Puerto Rico
5/22/09
5/31/13
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa
Diane Havlir, MD
HIV/AIDS , Malaria , Women's Health , Pediatrics
Uganda
8/1/13
6/30/18
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s)
Diane Havlir, MD
HIV/AIDS
United States
5/22/09
5/31/13
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262)
Diane Havlir, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
5/22/09
5/31/13
Therapeutic Strategies for HIV Disease
Diane Havlir, MD
HIV/AIDS
Uganda
4/1/08
3/31/15
AIDS Clinical Trials Group (ACTG) Community Health Promoter
Diane Havlir, MD
HIV/AIDS
Uganda
9/1/11
5/31/12
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects
Diane Havlir, MD
HIV/AIDS , Tuberculosis
United States
6/1/12
12/31/13
HIV/TB in Uganda: Punctuated Antiretroviral Therapy
Diane Havlir, MD
HIV/AIDS , Tuberculosis
Uganda ; South Africa
3/15/03
8/31/08
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A
Diane Havlir, MD
Infectious Disease , HIV/AIDS , Opportunistic Infection , Pharmacology and Drug Treatment
United States
10/30/09
10/31/10
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load
Diane Havlir, MD
HIV/AIDS
Haiti
6/1/11
5/31/12
Clinical Studies of Interactions Between HIV and Malaria
Diane Havlir, MD
HIV/AIDS , Malaria
Uganda
9/30/04
11/30/10
Adult AIDS Clinical Trials Unit (AACTU)
Diane Havlir, MD
HIV/AIDS
United States
1/1/00
12/31/06
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects
Diane Havlir, MD
HIV/AIDS , Tuberculosis
United States
2/1/12
5/31/12
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites
Diane Havlir, MD
HIV/AIDS , Engagement in Care , Health Systems Strengthening , Training and Capacity Building
Uganda
2/23/04
6/1/09
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I)
Diane Havlir, MD
HIV/AIDS , Malaria
Uganda
9/15/08
7/31/13
Training in HIV Translational Research
Diane Havlir, MD
Training and Capacity Building
United States
8/1/10
7/31/16
Task Order # 7: Supplement to SSS A5254
Diane Havlir, MD
HIV/AIDS , Opportunistic Infection , Oral Health
United States
6/1/10
5/31/11
Training in HIV Translational Research
Diane Havlir, MD
HIV/AIDS , Training and Capacity Building
United States
9/5/05
7/31/10
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1
Diane Havlir, MD
HIV/AIDS , Pharmacology and Drug Treatment
Uganda
1/1/12
8/31/14
Task Order # 6: Supplement to SSS A5257
Diane Havlir, MD
HIV/AIDS
United States
12/1/09
5/31/11
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position
Diane Havlir, MD
HIV/AIDS
United States
11/9/09
8/31/11
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites
Diane Havlir, MD
HIV/AIDS , Pediatrics
Kenya ; Uganda ; Tanzania ; Zimbabwe ; South Africa ; Ivory Coast
2/23/09
2/22/12
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART)
Diane Havlir, MD
HIV/AIDS
United States
6/1/11
5/31/13
Training in HIV Primary Care - Uganda Clinicians
Diane Havlir, MD
HIV/AIDS , Training and Capacity Building
Uganda
2/28/08
8/30/08
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS
Laurence Huang, MD
HIV/AIDS , Opportunistic Infection , Pharmacology and Drug Treatment
United States
9/1/06
8/31/08
Molecular Epidemiology of Human P. Carinii Pneumonia
Laurence Huang, MD
United States
7/1/03
3/31/07
Patient-Oriented Research and Mentoring in Pneumocystis
Laurence Huang, MD
Uganda
9/30/06
8/31/13
Specimens Related to the MU-UCSF Research Collaboration
Laurence Huang, MD
HIV/AIDS
Uganda
5/2/06
4/20/16
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study
Laurence Huang, MD
HIV/AIDS
United States
9/25/09
7/31/16
PCP OPW Specimens
Laurence Huang, MD
Opportunistic Infection
Uganda
6/5/03
9/30/04
International HIV-Associated Opportunistic Pneumonias (IHOP) Study
Laurence Huang, MD
HIV/AIDS
Uganda ; United Kingdom ; United States
7/1/09
6/30/11
International HIV-Associated Opportunistic Pneumonias (IHOP) Study
Laurence Huang, MD
HIV/AIDS
Uganda ; United Kingdom
9/28/07
12/31/14
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll)
Laurence Huang, MD
HIV/AIDS
United States
7/1/11
6/30/13
PCP OPW Specimens/Uganda Project Support
Laurence Huang, MD
Infectious Disease , HIV/AIDS , Opportunistic Infection
Uganda
10/1/06
9/30/09
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l))
Laurence Huang, MD
HIV/AIDS
United States
9/28/07
6/30/12
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial)
Laurence Huang, MD
HIV/AIDS
United States
7/1/13
6/30/15
FIND Xpert MTB assay collaboration at Mulago Hospital
Laurence Huang, MD
Tuberculosis
Uganda
8/1/09
7/31/11
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV
Laurence Huang, MD
HIV/AIDS , Chronic Respiratory Disease
United States
8/1/10
7/31/16
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease
Laurence Huang, MD
HIV/AIDS , Chronic Respiratory Disease
United States
7/1/09
6/30/11
UCSF-FIND Uganda Project
Laurence Huang, MD
Tuberculosis , Drug and Diagnostics Development
Uganda
10/1/07
12/31/08
The Determinants of T Cell Activation in HIV Infection
Peter Hunt, MD
HIV/AIDS
United States
4/15/05
3/31/10
HIV-Specific T-Cell Responses in Rectal Mucosa
Peter Hunt, MD
Immunology
United States
6/1/13
5/31/19
Innate Immune Response Genetics and T cell Activation in Treated HIV Infection
Peter Hunt, MD
HIV/AIDS
Uganda
5/22/09
4/30/11
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order
Peter Hunt, MD
HIV/AIDS
United States
6/1/11
5/31/12
Mesalamine to Reduce T Cell Activation in HIV Infection
Peter Hunt, MD
HIV/AIDS , Drug and Diagnostics Development
United States
4/1/10
3/31/13
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order
Peter Hunt, MD
HIV/AIDS
United States
6/1/12
12/31/13
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected Africans
Peter Hunt, MD
HIV/AIDS
Uganda
8/1/12
7/31/14
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection
Peter Hunt, MD
HIV/AIDS
United States
5/15/10
4/30/12
Immunologic Determinants of CD4+ T Cell Recovery in Treated HIV+ Africans
Peter Hunt, MD
HIV/AIDS
Uganda
8/1/08
1/31/13
HIV-Specific T-cell Responses in Rectal Mucosa
Peter Hunt, MD
HIV/AIDS
United States
9/1/10
8/31/12
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
Peter Hunt, MD
HIV/AIDS
Uganda
5/16/12
3/31/14
Valganciclovir to Reduce T Cell Activation in HIV Infection
Peter Hunt, MD
HIV/AIDS , Drug and Diagnostics Development , Immunology
United States
4/18/06
3/29/08
HIV Pathogenesis and Immunity in Viremic Non-Progressors
Peter Hunt, MD
HIV/AIDS
United States
8/1/10
7/31/12
Impact of Parasitemia on the Development of Cellular Immune Responses to Malaria
Malaria
Uganda
7/1/11
6/30/14
Immunologic Consequences of Highly Effective Antimalarial Chemoprevention
Malaria
Uganda ; Zimbabwe
5/1/12
4/30/16
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts
Vivek Jain, MD
HIV/AIDS , Pharmacology and Drug Treatment
Uganda
8/26/11
4/30/17
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART
HIV/AIDS
United States
8/1/09
2/29/12
Adherence Improvement & Measurement (AIM) System
Treatment Adherence
United States
9/30/09
8/31/12
HIV Emergence of Drug Resistance
Zoonosis, Emerging Disease, and Drug Resistance , HIV/AIDS , Pharmacology and Drug Treatment
South Africa
3/1/08
2/29/12
BMS-790052 with Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 1 Infected Subjects Who are Null or Partial Responders to Peginterferon Alfa plus
Mandana Khalili, MD
Mexico ; Argentina ; Puerto Rico ; Australia
9/27/10
8/31/13
Metabolic Substudy of A5257, CIMT/FMD Repeat Scans (ACTG A5260s:)
Anne Luetkemeyer, MD
HIV/AIDS
United States
7/1/10
6/30/12
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
4/18/11
8/17/13
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C
Anne Luetkemeyer, MD
Sexually Transmitted Infections (STIs)
United States
12/4/12
4/30/18
Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Subjects with Chronic Hepatitis C
Anne Luetkemeyer, MD
Sexually Transmitted Infections (STIs)
United States
12/4/12
4/30/18
ViiV Healthcare A4001098
Anne Luetkemeyer, MD
United States
4/12/11
4/11/16
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
1/31/06
12/31/08
ACTG, AIDS Clinical Trials Research Group - A5289 and A5255
Anne Luetkemeyer, MD
HIV/AIDS
United States
6/1/12
12/31/13
Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination with Ribavirin and Daclatasvir for Treatment of Chronic HCV Infection with Treatment Naïve Genotypes 1, 2, 3 or 4 in Subjects Coinfected with HIV-1
Anne Luetkemeyer, MD
HIV/AIDS
United States
7/11/13
7/11/17
Cepheid 077B-C: Evaluation of the Xpert® MTB/RIF Assay
Anne Luetkemeyer, MD
Tuberculosis
Uganda ; United States
6/1/11
5/31/12
A Probe to Evaluate the Safety, Tolerability & Immunogenicity of the MRK Adenovirus Serotype 5 Vector Human Immunodeficiency Virus Type 1 gag Vaccine in HIV-1 Infected
Anne Luetkemeyer, MD
HIV/AIDS
United States
8/1/02
7/31/08
Pfizer A4001027: Observational Phase Extension
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
5/13/08
6/30/12
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy with Genotype 1 Chronic Hepatitis C
Anne Luetkemeyer, MD
Sexually Transmitted Infections (STIs)
France ; Germany ; Hungary ; Spain ; Argentina
8/1/12
8/1/14
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy (ACTG) A5260s
Anne Luetkemeyer, MD
HIV/AIDS
United States
6/1/09
6/30/13
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects
Anne Luetkemeyer, MD
HIV/AIDS , Tuberculosis
United States
3/1/12
9/30/14
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men
Anne Luetkemeyer, MD
HIV/AIDS , Cancer/Oncology
Brazil ; Puerto Rico
3/22/12
3/21/15
GS-US-183-0130: A Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents in the Treatment of HIV-1 Infected Subjects
Anne Luetkemeyer, MD
HIV/AIDS
United States
4/6/07
10/1/16
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions
Anne Luetkemeyer, MD
HIV/AIDS , Pharmacology and Drug Treatment
United States
3/15/07
3/15/10
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia
Anne Luetkemeyer, MD
Infectious Disease , HIV/AIDS , Pharmacology and Drug Treatment
United States
1/28/08
12/31/10
ACTG A5294: A Prospective, Phase III Open-Label Study of Response-Guided Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects
Anne Luetkemeyer, MD
HIV/AIDS
United States
5/8/12
5/7/17
Study of BMS-790052 plus Peg-Interferon alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with HIV and HCV
Anne Luetkemeyer, MD
HIV/AIDS
France ; Germany ; Italy ; Russia ; Spain ; United Kingdom ; Argentina ; Puerto Rico ; Canada ; Australia
11/28/11
3/31/15
Novel Approaches to Monitoring and Utilizing Adherence to HIV Therapy in Africa
Jeffrey Martin, MD, MPH
HIV/AIDS , Implementation and Behavioral Science , Treatment Adherence
Uganda
7/1/10
12/31/15
T Regulatory Cells in HIV Infection
HIV/AIDS
United States
7/1/06
5/31/12
HIV RNA and/or Antibody Confirmed Positive Plasma
Christopher Pilcher, MD
HIV/AIDS
South Africa
11/4/11
11/3/16
Development of Specimen Repository and Evaluation of Assays for Identification of Recent HIV Infection
Christopher Pilcher, MD
HIV/AIDS
South Africa
4/1/11
12/31/14
Performance Evaluation of the Bio-Rad Geenius HIV-1/2 Supplemental Assay
Christopher Pilcher, MD
HIV/AIDS , Drug and Diagnostics Development
United States
8/20/13
3/19/15
High Throughput Measurement of Envelope Gene Diversity for an HIV Incidence Assay
Christopher Pilcher, MD
HIV/AIDS , Drug and Diagnostics Development
United States
7/1/13
12/31/14
Data Collected through the IAVI Early Infection Cohort Study
Christopher Pilcher, MD
HIV/AIDS
United States
3/1/11
2/29/16
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
Richard Price, MD
HIV/AIDS
United States
3/1/09
5/31/15
Ghana: UCSF Technical Assistance to Support PEPFAR
George Rutherford, MD
HIV/AIDS , Epidemiology and Surveillance , Implementation and Behavioral Science
Ghana
4/1/09
6/30/15
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
Ann Schwartz, PhD, MPH
HIV/AIDS
South Africa ; India ; Thailand ; Belgium ; Ireland ; Italy ; Spain ; United Kingdom ; Brazil ; Peru ; Australia
6/1/10
5/31/16
HIV and HPV Transmission across Mucosal Epithelia
Sharof Tugizov, PhD
HIV/AIDS
United States
9/1/11
8/31/13
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda
Sheri Weiser, MD
HIV/AIDS , Malnutrition, Micronutrients, Food Insecurity , Implementation and Behavioral Science , Risk Reduction and Prevention
Uganda
4/1/07
3/31/13
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda
Sheri Weiser, MD
HIV/AIDS , Malnutrition, Micronutrients, Food Insecurity , Risk Reduction and Prevention
Uganda
7/1/09
6/30/11
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV
Sheri Weiser, MD
HIV/AIDS , Malnutrition, Micronutrients, Food Insecurity , Women's Health
United States
9/1/12
11/30/16
Exploring the Bidirectional Relationship between Food Security and HIV Treatment Outcomes in a Rural Ugandan Cohort
Sheri Weiser, MD
HIV/AIDS , Malnutrition, Micronutrients, Food Insecurity , Treatment Adherence
Uganda
5/1/12
10/1/13
Food Insecurity: A Key Structural Barrier to HIV/AIDS Care
Sheri Weiser, MD
HIV/AIDS , Malnutrition, Micronutrients, Food Insecurity , Access or Barriers to Care , Implementation and Behavioral Science
United States
4/1/09
3/31/12
Women's Center of Excellence
HIV/AIDS , Women's Health , Engagement in Care , Treatment Adherence , Health Systems Strengthening , Patient and Peer Education
United States
3/1/11
2/29/20
VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1)
Sexually Transmitted Infections (STIs) , HIV/AIDS
United States
4/9/12
4/8/14
HIV Treatment Training for Clinical Setting
HIV/AIDS , Residencies, Fellowships, and Postdoctoral Training
United States
6/27/07
8/31/07
Positive Health Access to Service and Treatment (PHAST)
HIV/AIDS , Engagement in Care
United States
7/1/05
6/30/07
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP)
HIV/AIDS , Neurology and Mental Health
United States
3/1/10
2/28/11
Family Service Networks - Centers of Excellence
HIV/AIDS
United States
11/1/05
2/29/12
Positive Health Access to Service and Treatment (PHAST)
HIV/AIDS , Access or Barriers to Care , Health Systems Strengthening
United States
7/1/06
6/30/07
Chronic Care HIV/AIDS Multi-Disciplinary Program (CCHAMP)
HIV/AIDS
United States
11/1/05
2/28/10
Treatment of Acute Hepatitis C Virus in HIV Co-Infection
Sexually Transmitted Infections (STIs) , HIV/AIDS
United States
9/1/06
8/31/09
KAM Training
United States
3/18/13
12/31/13
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) Center of Excellence
HIV/AIDS , Engagement in Care , Treatment Adherence , Risk Reduction and Prevention , UCSF Professional Education , Patient and Peer Education
United States
3/1/11
6/30/19
Ryan White Title IV Program: Family Services Network
HIV/AIDS
United States
8/1/07
7/31/12
Abbott Preceptorship
HIV/AIDS
United States
8/31/07
8/30/08
Evaluation of Adherence to National Guidelines on HIV Prevention for HIV-infected Patients in Clinical Care in Nine US Clinics Who Serve Men Who Have Sex with Men (MSM)
HIV/AIDS , Systematic Reviews and Guideline Development , Treatment Adherence , Health Systems Strengthening
United States
2/1/07
8/31/07
Primary Care Services- Non Severe Need - Ward 86
HIV/AIDS
United States
11/1/05
2/28/06
Ward 86 Outpatient Services/Perinatal Services
HIV/AIDS , Patient and Peer Education
United States
4/1/08
3/31/09
Ward 86 Outpatient Services/Perinatal Services
HIV/AIDS , Newborn and Infant Health
United States
4/1/09
6/30/10
Hepatitis C Co-infection Clinic: A to T (Acute to Transplant)
Sexually Transmitted Infections (STIs) , HIV/AIDS
United States
9/1/10
8/31/12
She's Living Positive Health Fair
HIV/AIDS , Patient and Peer Education
United States
12/15/09
3/30/10
Ward 86 Outpatient Services / Perinatal Services
HIV/AIDS , Women's Health , Newborn and Infant Health
United States
7/1/10
6/30/20
HIV Health Services - Program Database Services
HIV/AIDS
United States
3/15/07
6/30/07
African American Center of Excellence
HIV/AIDS , Access or Barriers to Care , Stigma and Discrimination , Engagement in Care , Health Systems Strengthening , Patient and Peer Education
United States
3/1/11
6/30/19
Sexual Harm Reduction for HIV+ Gay Men (Prevention with Positives)
HIV/AIDS , Risk Reduction and Prevention
United States
7/1/06
9/30/11
The Use of Nelfinavir During Acute or Early HIV Infection - Safety, Tolerability, Durablilty and Resistance
HIV/AIDS , Pharmacology and Drug Treatment
United States
8/5/05
5/13/06
Positive Health Access to Services and Treatment (PHAST)
HIV/AIDS
United States
3/1/11
6/30/16
Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Who Have Chronic HCV-1/HIV-1 Co-Infection and Are Treatment-Naïve for Hepatitis C
Infectious Disease , HIV/AIDS
United States
1/20/10
1/19/13
Expanded HIV Testing for Disproportionately Affected Population
HIV/AIDS
United States
1/1/11
6/30/20
Family Services Network - Ryan White HIV/AIDS Program
Infectious Disease , HIV/AIDS , Systematic Reviews and Guideline Development
United States
8/1/12
7/31/15
CHRP for Integrating HIV and Geriatric for People Living with HIV 50 and Over
HIV/AIDS , Engagement in Care , Health Systems Strengthening
United States
12/1/10
6/30/15
Ultra-Low Viral Detection Using the Abbott RealTime HIV-1 Assay
HIV/AIDS , Drug and Diagnostics Development
United States
1/12/09
1/11/10
Ultrasensitive Monitoring of HIV-1 Drug Resistance Reversion Following Transmission with Drug Resistant Virus
HIV/AIDS , Pharmacology and Drug Treatment , Women's Health , Newborn and Infant Health
Botswana
6/14/10
6/13/11
Probing Below the Surface: Development of a Molecular Diagnostic Assay to Detect Emergent Viral Escape Variants
HIV/AIDS , Drug and Diagnostics Development
United States
7/1/08
6/30/09
HIV Vaccine Trials Network - Laboratory Personnel Support
Immunology
Malawi ; Mozambique ; South Africa ; China ; Peru
8/1/05
12/31/07
Effects of Housing and HIV on Risk Behavior and Victimization of Indigent Women
Elise Riley, PhD
HIV/AIDS , Women's Health
United States
7/1/07
6/30/13
Environment and HIV Risks among Unstably Housed Women
Elise Riley, PhD
HIV/AIDS , Women's Health , Access or Barriers to Care
United States
9/1/06
11/30/08
HPV Epidemiology and Response to Screening (HEARTS)
Elise Riley, PhD
United States
8/11/09
7/31/11
The Influence of Pharmacy-Based Syringe Disposal on Unsafe Syringe Discard Among Injection Drug Users in California
Elise Riley, PhD
Substance Abuse , Risk Reduction and Prevention
United States
9/1/06
6/30/09
Drugs, Gender and Healthcare Use among HIV+ Homeless
Elise Riley, PhD
HIV/AIDS , Neurology and Mental Health , Substance Abuse
United States
9/30/03
6/30/07
Administering Buprenorphine in the San Francisco County Jail
Jacqueline Tulsky, MD
Access or Barriers to Care , Substance Abuse
United States
1/1/07
5/31/09
Seek, Test, Treat and Retain Strategies Leveraging Mobile Health and Internet-Based Technologies
Jacqueline Tulsky, MD
United States
7/15/11
7/4/17
A Clinical Trial of DOT for HAART in Jailed Drug Users / AIDS Related
Jacqueline Tulsky, MD
HIV/AIDS
United States
9/25/01
8/31/06
Crossing Boundaries: Continuity of Medical Care for Incarcerated Adults
Jacqueline Tulsky, MD
HIV/AIDS , Access or Barriers to Care
United States
7/1/02
3/31/05